- Home
- MRNA vs MTD Comparison
MRNA vs MTD Comparison
Compare MRNA & MTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | MTD |
|---|---|---|
| Founded | 2010 | 1991 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 23.1B |
| IPO Year | 2018 | 1997 |
Fundamental Metrics
Financial Performance| Metric | MRNA | MTD |
|---|---|---|
| Price | $54.50 | $1,416.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $34.27 | ★ $1,444.17 |
| AVG Volume (30 Days) | ★ 6.0M | 154.2K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.77 | 3.88 |
| EPS | N/A | ★ 8.33 |
| Revenue | ★ $19,263,000,000.00 | $4,026,399,000.00 |
| Revenue This Year | $9.36 | $6.07 |
| Revenue Next Year | $15.43 | $4.75 |
| P/E Ratio | ★ N/A | $165.63 |
| Revenue Growth | ★ 4.29 | 3.98 |
| 52 Week Low | $22.28 | $1,023.05 |
| 52 Week High | $85.60 | $1,525.17 |
Technical Indicators
Market Signals| Indicator | MRNA | MTD |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 67.81 |
| Support Level | $45.09 | $1,365.95 |
| Resistance Level | $59.52 | $1,411.61 |
| Average True Range (ATR) | 2.79 | 38.69 |
| MACD | -1.28 | 4.69 |
| Stochastic Oscillator | 20.90 | 69.76 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About MTD Mettler-Toledo International Inc.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.